NYSE:XAN - Exantas Capital Stock Price, News & Analysis

-0.04 (-0.35 %)
(As of 09/17/2019 11:10 AM ET)
Today's Range
Now: $11.51
50-Day Range
MA: $11.30
52-Week Range
Now: $11.51
Volume100 shs
Average Volume107,385 shs
Market Capitalization$366.82 million
P/E Ratio16.21
Dividend Yield7.81%
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments related to commercial real estate (CRE), commercial mortgage-backed securities, and CRE equity investments. Read More…

Industry, Sector and Symbol

Industry Real estate investment trusts



Sales & Book Value

Annual Sales$55.28 million
Cash Flow$0.8820 per share
Book Value$17.49 per share


Net Income$27.43 million


Market Cap$366.82 million
Next Earnings Date10/29/2019 (Estimated)

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

Exantas Capital (NYSE:XAN) Frequently Asked Questions

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital declared a quarterly dividend on Thursday, September 12th. Stockholders of record on Monday, September 30th will be given a dividend of $0.25 per share on Friday, October 25th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.69%. The ex-dividend date is Friday, September 27th. This is a positive change from Exantas Capital's previous quarterly dividend of $0.23. View Exantas Capital's Dividend History.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) issued its earnings results on Tuesday, October, 30th. The company reported $0.24 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.04. The company earned $14.51 million during the quarter, compared to analyst estimates of $14.60 million. Exantas Capital had a net margin of 59.04% and a return on equity of 7.03%. View Exantas Capital's Earnings History.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Exantas Capital.

What price target have analysts set for XAN?

2 analysts have issued 1 year price targets for Exantas Capital's shares. Their forecasts range from $11.54 to $13.00. On average, they expect Exantas Capital's share price to reach $12.27 in the next twelve months. This suggests a possible upside of 6.6% from the stock's current price. View Analyst Price Targets for Exantas Capital.

What is the consensus analysts' recommendation for Exantas Capital?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exantas Capital.

Has Exantas Capital been receiving favorable news coverage?

News coverage about XAN stock has been trending negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Exantas Capital earned a coverage optimism score of -2.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Exantas Capital.

Are investors shorting Exantas Capital?

Exantas Capital saw a drop in short interest in the month of August. As of August 31st, there was short interest totalling 848,500 shares, a drop of 11.9% from the July 31st total of 962,700 shares. Based on an average daily volume of 145,700 shares, the short-interest ratio is presently 5.8 days. Approximately 2.7% of the shares of the company are sold short. View Exantas Capital's Current Options Chain.

Who are some of Exantas Capital's key competitors?

What other stocks do shareholders of Exantas Capital own?

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the folowing people:
  • Mr. Robert C. Lieber, Chief Exec. Officer (Age 65)
  • Mr. Matthew J. Stern, Pres (Age 45)
  • Mr. David J. Bryant, Sr. VP, CFO & Treasurer (Age 61)
  • Mr. Thomas C. Elliott, Exec. VP of Fin. & Operations (Age 46)
  • Mr. Eldron C. Blackwell, VP & Chief Accounting Officer (Age 40)

Who are Exantas Capital's major shareholders?

Exantas Capital's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.04%), Vanguard Group Inc. (5.17%), Northern Trust Corp (2.47%), Acadian Asset Management LLC (2.22%), Ancora Advisors LLC (1.67%) and Nuveen Asset Management LLC (1.00%). View Institutional Ownership Trends for Exantas Capital.

Which institutional investors are selling Exantas Capital stock?

XAN stock was sold by a variety of institutional investors in the last quarter, including Ancora Advisors LLC, Acadian Asset Management LLC, Marshall Wace LLP, Citadel Advisors LLC, Invesco Ltd., Prudential Financial Inc., Grantham Mayo Van Otterloo & Co. LLC and Alberta Investment Management Corp. View Insider Buying and Selling for Exantas Capital.

Which institutional investors are buying Exantas Capital stock?

XAN stock was bought by a variety of institutional investors in the last quarter, including Northern Trust Corp, Nuveen Asset Management LLC, BlackRock Inc., LSV Asset Management, Renaissance Technologies LLC, GSA Capital Partners LLP, Bank of America Corp DE and Wells Fargo & Company MN. View Insider Buying and Selling for Exantas Capital.

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $11.51.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $366.82 million and generates $55.28 million in revenue each year. The company earns $27.43 million in net income (profit) each year or $0.71 on an earnings per share basis. View Additional Information About Exantas Capital.

What is Exantas Capital's official website?

The official website for Exantas Capital is http://www.exantas.com/.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]

MarketBeat Community Rating for Exantas Capital (NYSE XAN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  28 (Vote Underperform)
Total Votes:  65
MarketBeat's community ratings are surveys of what our community members think about Exantas Capital and other stocks. Vote "Outperform" if you believe XAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel